These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33228665)

  • 1. Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.
    Zhou L; Yin S; Chai W; Zhao Q; Tian G; Xu D; Jiang T
    World J Surg Oncol; 2020 Nov; 18(1):305. PubMed ID: 33228665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors.
    Chai W; Xie L; Zhao Q; Cheng C; Tian G; Jiang T; Wu P
    Ultrasound Med Biol; 2020 Mar; 46(3):620-629. PubMed ID: 31924420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous irreversible electroporation of hepatocellular carcinoma: Contrast-enhanced ultrasound-findings during 1-year follow-up.
    Niessen C; Beyer LP; Haimerl M; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 72(1):85-93. PubMed ID: 30584122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound and Contrast-Enhanced Ultrasound for Evaluation of Irreversible Electroporation Ablation: In Vivo Proof of Concept in Normal Porcine Liver.
    Lin MX; Kuang M; Xu M; Zhuang BW; Tian WS; Ye JY; Xie XH; Xie XY
    Ultrasound Med Biol; 2016 Nov; 42(11):2639-2649. PubMed ID: 27546157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings.
    Wiggermann P; Zeman F; Niessen C; Agha A; Trabold B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2012; 52(2-4):417-27. PubMed ID: 22986756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
    van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality imaging to assess immediate response following irreversible electroporation in patients with malignant hepatic tumors.
    Sugimoto K; Moriyasu F; Saito K; Kobayashi Y; Itoi T
    J Med Ultrason (2001); 2017 Jul; 44(3):247-254. PubMed ID: 27933441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
    Beyer LP; Pregler B; Nießen C; Michalik K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2016; 64(3):501-506. PubMed ID: 27935553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
    Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings.
    Niessen C; Jung EM; Beyer L; Pregler B; Dollinger M; Haimerl M; Scheer F; Stroszczynski C; Wiggermann P
    Clin Hemorheol Microcirc; 2015; 61(2):135-41. PubMed ID: 26410867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatment.
    Jung EM; Engel M; Wiggermann P; Schicho A; Lerchbaumer M; Stroszczynski C; Fischer T; Wiesinger I
    Clin Hemorheol Microcirc; 2021; 77(3):303-310. PubMed ID: 33337354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
    Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
    Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.
    Figini M; Zhou K; Pan L; Sun C; Wang B; Hu S; Yang J; Shangguan J; Eresen A; Velichko Y; Yaghmai V; Zhang Z
    Magn Reson Med; 2020 Jul; 84(1):365-374. PubMed ID: 31850550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
    J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.
    Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.
    Guo Y; Zhang Y; Nijm GM; Sahakian AV; Yang GY; Omary RA; Larson AC
    Radiology; 2011 Feb; 258(2):461-8. PubMed ID: 21131581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.